Literature DB >> 2561592

Cisplatin neurotoxicity.

R J Cersosimo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2561592     DOI： 10.1016/0305-7372(89)90041-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  18 in total

1.  Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate.

Authors:  F M Boyle; H R Wheeler; G M Shenfield
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer.

Authors:  T J Postma; K Hoekman; J M van Riel; J J Heimans; J B Vermorken
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

3.  Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.

Authors:  Lauren E Ta; Allan J Bieber; Susan M Carlton; Charles L Loprinzi; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2010-03-05       Impact factor: 3.395

4.  Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.

Authors:  Ying Guo; Desiree Jones; J Lynn Palmer; Arthur Forman; Shaker R Dakhil; Maria R Velasco; Matthias Weiss; Paul Gilman; G M Mills; Stephen J Noga; Cathy Eng; Michael J Overman; Michael J Fisch
Journal:  Support Care Cancer       Date:  2013-12-22       Impact factor: 3.603

5.  A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).

Authors:  Janet M Schloss; Maree Colosimo; Caroline Airey; Paul Masci; Anthony W Linnane; Luis Vitetta
Journal:  Support Care Cancer       Date:  2016-09-09       Impact factor: 3.603

Review 6.  Comparative adverse effect profiles of platinum drugs.

Authors:  M J McKeage
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

7.  Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes.

Authors:  Jonah A Kaplan; Rong Liu; Jonathan D Freedman; Robert Padera; John Schwartz; Yolonda L Colson; Mark W Grinstaff
Journal:  Biomaterials       Date:  2015-10-27       Impact factor: 12.479

8.  Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.

Authors:  Jan Oldenburg; Sophie D Fosså; Alv A Dahl
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 3.440

9.  Neurotoxicity caused by the treatment with platinum analogues.

Authors:  Sousana Amptoulach; Nicolas Tsavaris
Journal:  Chemother Res Pract       Date:  2011-06-27

10.  Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients.

Authors:  F E de Jongh; R N van Veen; S J Veltman; R de Wit; M E L van der Burg; M J van den Bent; A S Th Planting; W J Graveland; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.